Condition: Type 1 Diabetes · Type 1 Diabetes Mellitus · Diabetes (DM) · Sponsor: Insulet Corporation
Feasibility study to evaluate the safety and feasibility of Omnipod automated insulin delivery algorithms in individuals with type 1 diabetes. This study will enroll up to 80 participants to have a minimum of 48 participants to initiate the use of Omnipod. The study will include hotel and outpatient evaluation periods.
This description comes directly from the study's public registry record.
Trang Ly, MBBS, PhD · 978-600-7000 · APClinical@insulet.com
Bonnie Dumais, RN · 978-600-7000 · APClinical@insulet.com
Always discuss trial participation with your own doctor first.
| University of Otago | Christchurch, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07593625